These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 32057296)

  • 1. Functional heterogeneity of lymphocytic patterns in primary melanoma dissected through single-cell multiplexing.
    Bosisio FM; Antoranz A; van Herck Y; Bolognesi MM; Marcelis L; Chinello C; Wouters J; Magni F; Alexopoulos L; Stas M; Boecxstaens V; Bechter O; Cattoretti G; van den Oord J
    Elife; 2020 Feb; 9():. PubMed ID: 32057296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic heterogeneity of tumor-infiltrating lymphocyte composition in primary melanoma.
    Weiss SA; Han SW; Lui K; Tchack J; Shapiro R; Berman R; Zhong J; Krogsgaard M; Osman I; Darvishian F
    Hum Pathol; 2016 Nov; 57():116-125. PubMed ID: 27473267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic significance of tumor-infiltrating lymphocytes for primary melanoma varies by sex.
    Sinnamon AJ; Sharon CE; Song Y; Neuwirth MG; Elder DE; Xu X; Chu EY; Ming ME; Fraker DL; Gimotty PA; Karakousis GC
    J Am Acad Dermatol; 2018 Aug; 79(2):245-251. PubMed ID: 29518458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma.
    Clemente CG; Mihm MC; Bufalino R; Zurrida S; Collini P; Cascinelli N
    Cancer; 1996 Apr; 77(7):1303-10. PubMed ID: 8608507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping the single cell spatial immune landscapes of the melanoma microenvironment.
    Magrill J; Moldoveanu D; Gu J; Lajoie M; Watson IR
    Clin Exp Metastasis; 2024 Aug; 41(4):301-312. PubMed ID: 38217840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-infiltrating lymphocyte response in cutaneous melanoma in the elderly predicts clinical outcomes.
    Grotz TE; Vaince F; Hieken TJ
    Melanoma Res; 2013 Apr; 23(2):132-7. PubMed ID: 23344159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor infiltrating lymphocytes in malignant melanoma - allies or foes?
    Zidlik V; Bezdekova M; Brychtova S
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Mar; 164(1):43-48. PubMed ID: 31649385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma.
    Taylor RC; Patel A; Panageas KS; Busam KJ; Brady MS
    J Clin Oncol; 2007 Mar; 25(7):869-75. PubMed ID: 17327608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Retrospective, Observational Analysis of Tumor Infiltrating Lymphocytes and Tumor Regression in Melanoma.
    Zaladonis A; Farma J; Hill M; Hotz M; Meller K; Board T; Deng M; Wu H; Reddy S; O'Halloran E
    J Surg Res; 2021 Nov; 267():203-208. PubMed ID: 34153563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor infiltrating lymphocytes in lymph node melanoma metastases: a histopathologic prognostic indicator and an expression of local immune response.
    Mihm MC; Clemente CG; Cascinelli N
    Lab Invest; 1996 Jan; 74(1):43-7. PubMed ID: 8569196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased tumor-infiltrating lymphocytes in nodular melanomas compared with matched superficial spreading melanomas.
    Lin RL; Wang TJ; Joyce CJ; Mihm MC; Murphy GF; Lian CG; Lin JY
    Melanoma Res; 2016 Oct; 26(5):524-7. PubMed ID: 26974966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A morphological and immunophenotypic map of the immune response in Merkel cell carcinoma.
    Walsh NM; Fleming KE; Hanly JG; Dakin Hache K; Doucette S; Ferrara G; Cerroni L
    Hum Pathol; 2016 Jun; 52():190-6. PubMed ID: 26980039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic landscape of adaptive immune resistance signatures and infiltrating immune cells in the tumor microenvironment of uveal melanoma.
    Wang Y; Xu Y; Dai X; Lin X; Shan Y; Ye J
    Exp Eye Res; 2020 Jul; 196():108069. PubMed ID: 32439398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-infiltrating lymphocytes and their significance in melanoma prognosis.
    Schatton T; Scolyer RA; Thompson JF; Mihm MC
    Methods Mol Biol; 2014; 1102():287-324. PubMed ID: 24258985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Connecting the Dots: Therapy-Induced Senescence and a Tumor-Suppressive Immune Microenvironment.
    Vilgelm AE; Johnson CA; Prasad N; Yang J; Chen SC; Ayers GD; Pawlikowski JS; Raman D; Sosman JA; Kelley M; Ecsedy JA; Shyr Y; Levy SE; Richmond A
    J Natl Cancer Inst; 2016 Jun; 108(6):djv406. PubMed ID: 26719346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic characterisation of immune cells associated with histological regression in cutaneous melanoma.
    Osella-Abate S; Conti L; Annaratone L; Senetta R; Bertero L; Licciardello M; Caliendo V; Picciotto F; Quaglino P; Cassoni P; Ribero S
    Pathology; 2019 Aug; 51(5):487-493. PubMed ID: 31266597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cells isolated from patients with checkpoint inhibitor-resistant melanoma are functional and can mediate tumor regression.
    Andersen R; Borch TH; Draghi A; Gokuldass A; Rana MAH; Pedersen M; Nielsen M; Kongsted P; Kjeldsen JW; Westergaard MCW; Radic HD; Chamberlain CA; Hölmich LR; Hendel HW; Larsen MS; Met Ö; Svane IM; Donia M
    Ann Oncol; 2018 Jul; 29(7):1575-1581. PubMed ID: 29688262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tumour immune landscape and its implications in cutaneous melanoma.
    Attrill GH; Ferguson PM; Palendira U; Long GV; Wilmott JS; Scolyer RA
    Pigment Cell Melanoma Res; 2021 May; 34(3):529-549. PubMed ID: 32939993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-associated B cells in cutaneous primary melanoma and improved clinical outcome.
    Garg K; Maurer M; Griss J; Brüggen MC; Wolf IH; Wagner C; Willi N; Mertz KD; Wagner SN
    Hum Pathol; 2016 Aug; 54():157-64. PubMed ID: 27107457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune biomarkers are more accurate in prediction of survival in ulcerated than in non-ulcerated primary melanomas.
    de Moll EH; Fu Y; Qian Y; Perkins SH; Wieder S; Gnjatic S; Remark R; Bernardo SG; Moskalenko M; Yao J; Ferringer T; Chang R; Chipuk J; Horst BA; Birge MB; Phelps RG; Saenger YM
    Cancer Immunol Immunother; 2015 Sep; 64(9):1193-203. PubMed ID: 26076664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.